Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 12751624)

1.

Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

Edagwa BJ, Zhou T, McMillan JM, Liu XM, Gendelman HE.

Curr Med Chem. 2014;21(36):4186-98.

2.

P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model.

Adkins CE, Mittapalli RK, Manda VK, Nounou MI, Mohammad AS, Terrell TB, Bohn KA, Yasemin C, Grothe TR, Lockman JA, Lockman PR.

Front Pharmacol. 2013 Nov 4;4:136. doi: 10.3389/fphar.2013.00136. eCollection 2013.

3.

Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization.

Pagar K, Vavia P.

Sci Pharm. 2013 Mar 28;81(3):865-85. doi: 10.3797/scipharm.1211-20. eCollection 2013.

4.

Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.

Mittapalli RK, Manda VK, Bohn KA, Adkins CE, Lockman PR.

J Neurosci Methods. 2013 Sep 30;219(1):188-95. doi: 10.1016/j.jneumeth.2013.07.001. Epub 2013 Aug 2.

5.

The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.

Bernardi A, Frozza RL, Hoppe JB, Salbego C, Pohlmann AR, Battastini AM, Guterres SS.

Int J Nanomedicine. 2013;8:711-28. doi: 10.2147/IJN.S40284. Epub 2013 Feb 18.

6.

The effect of ventilation, age, and asthmatic condition on ultrafine particle deposition in children.

Olvera HA, Perez D, Clague JW, Cheng YS, Li WW, Amaya MA, Burchiel SW, Berwick M, Pingitore NE.

Pulm Med. 2012;2012:736290. doi: 10.1155/2012/736290. Epub 2012 Jul 11.

7.

Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system.

Estevanato L, Cintra D, Baldini N, Portilho F, Barbosa L, Martins O, Lacava B, Miranda-Vilela AL, Tedesco AC, Báo S, Morais PC, Lacava ZG.

Int J Nanomedicine. 2011;6:1709-17. doi: 10.2147/IJN.S21323. Epub 2011 Aug 18.

8.

Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.

Wang J, Chen Y, Chen B, Ding J, Xia G, Gao C, Cheng J, Jin N, Zhou Y, Li X, Tang M, Wang XM.

Int J Nanomedicine. 2010 Oct 21;5:861-6. doi: 10.2147/IJN.S13662.

9.

In vivo methods to study uptake of nanoparticles into the brain.

van Rooy I, Cakir-Tascioglu S, Hennink WE, Storm G, Schiffelers RM, Mastrobattista E.

Pharm Res. 2011 Mar;28(3):456-71. doi: 10.1007/s11095-010-0291-7. Epub 2010 Oct 7. Review.

10.
11.

Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.

Chen L, Yokel RA, Hennig B, Toborek M.

J Neuroimmune Pharmacol. 2008 Dec;3(4):286-95. doi: 10.1007/s11481-008-9131-5. Epub 2008 Oct 1.

12.

Drug delivery and nanoparticles:applications and hazards.

De Jong WH, Borm PJ.

Int J Nanomedicine. 2008;3(2):133-49. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk